• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中西医结合治疗广泛期小细胞肺癌:1例报告

Extensive small cell lung cancer treated by integrated traditional Chinese and Western medicine: A case report.

作者信息

Yang Yuanqing, Li Si

机构信息

Department of Acupuncture and Moxibustion, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, P.R. China.

出版信息

Medicine (Baltimore). 2025 Jan 17;104(3):e41291. doi: 10.1097/MD.0000000000041291.

DOI:10.1097/MD.0000000000041291
PMID:39833064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749585/
Abstract

RATIONALE

Patients with extensive small cell lung cancer (SCLC) generally have a dismal survival rate and are conventionally treated with chemotherapy. This study aimed to explore an alternative treatment approach by combining traditional Chinese medicine (TCM) with radiotherapy and chemotherapy.

PATIENT CONCERNS

A 68-year-old male was diagnosed with extensive-stage SCLC. Positron emission tomography/computed tomography scans indicated a high metabolism mass in the left hilar region, along with multiple lymph node metastases and metastatic tumors in both lungs. A left lung biopsy verified small cell carcinoma.

DIAGNOSES

The patient was confirmed to have extensive stage SCLC based on imaging and biopsy results.

INTERVENTIONS

The patient received a comprehensive treatment regimen. TCM herbal prescriptions such as Qianjin Weijing Decoction, Wuwei Xiaodu Decoction, Xiaoxianxiong Decoction, and Xiaochengqi Decoction were administered. In parallel, standard Western medicine therapies, including chemotherapy (intravenous cisplatin and etoposide) and radiotherapy, were carried out. Oral ondansetron was given to alleviate nausea and vomiting caused by chemotherapy and radiotherapy.

OUTCOMES

After 30 months, follow-up positron emission tomography/computed tomography demonstrated the complete disappearance of all cancerous lesions. The patient regained normal daily activities and experienced a substantially enhanced quality of life. Four years after the initial treatment, there has been no recurrence, and the patient persists in taking the original TCM decoction.

LESSONS

The combination of TCM and Western medicine in treating SCLC proves effective in managing systemic symptoms, mitigating bone marrow suppression, gastrointestinal reactions, immunosuppression, and other chemotherapy-induced adverse reactions. It also significantly prolongs the survival period, suggesting it as a preferable treatment option for SCLC.

摘要

理论依据

广泛期小细胞肺癌(SCLC)患者的生存率通常很低,传统上采用化疗进行治疗。本研究旨在探索一种将中医与放疗和化疗相结合的替代治疗方法。

患者情况

一名68岁男性被诊断为广泛期SCLC。正电子发射断层扫描/计算机断层扫描显示左肺门区有一个高代谢肿块,同时伴有双肺多发淋巴结转移和转移瘤。左肺活检证实为小细胞癌。

诊断

根据影像学和活检结果,该患者被确诊为广泛期SCLC。

干预措施

患者接受了综合治疗方案。给予千金苇茎汤、五味消毒饮、小陷胸汤和小承气汤等中药方剂。同时,进行了标准的西医治疗,包括化疗(静脉注射顺铂和依托泊苷)和放疗。口服昂丹司琼以减轻化疗和放疗引起的恶心和呕吐。

结果

30个月后,随访的正电子发射断层扫描/计算机断层扫描显示所有癌性病变完全消失。患者恢复了正常的日常活动,生活质量大幅提高。初始治疗四年后,无复发,患者持续服用原中药汤剂。

经验教训

中西医结合治疗SCLC在控制全身症状、减轻骨髓抑制、胃肠道反应、免疫抑制和其他化疗引起的不良反应方面被证明是有效的。它还显著延长了生存期,表明它是SCLC的一种较好的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/11749585/a741443e7113/medi-104-e41291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/11749585/b44aff5d56ea/medi-104-e41291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/11749585/a741443e7113/medi-104-e41291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/11749585/b44aff5d56ea/medi-104-e41291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/11749585/a741443e7113/medi-104-e41291-g002.jpg

相似文献

1
Extensive small cell lung cancer treated by integrated traditional Chinese and Western medicine: A case report.中西医结合治疗广泛期小细胞肺癌:1例报告
Medicine (Baltimore). 2025 Jan 17;104(3):e41291. doi: 10.1097/MD.0000000000041291.
2
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis.中医药联合化疗治疗小细胞肺癌的疗效和安全性:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2020 Nov;146(11):2913-2935. doi: 10.1007/s00432-020-03353-0. Epub 2020 Aug 14.
3
Lung cancer palindromia due to the deficiency of vital energy and blood syndrome treated by TCM herbs: A case report.中医药治疗气血亏虚型肺癌回阳证1例报告
Medicine (Baltimore). 2025 Jan 3;104(1):e41203. doi: 10.1097/MD.0000000000041203.
4
The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report.18F-FDG PET/CT在副肿瘤性边缘叶脑炎合并小细胞肺癌管理中的作用:一例报告
Medicine (Baltimore). 2019 Aug;98(35):e16593. doi: 10.1097/MD.0000000000016593.
5
Staging and imaging of small cell lung cancer.小细胞肺癌的分期和影像学检查。
Cancer Imaging. 2012 Jan 12;11(1):253-8. doi: 10.1102/1470-7330.2011.0036.
6
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.正电子发射断层扫描/计算机断层扫描引导下的调强放疗用于局限期小细胞肺癌。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e91-7. doi: 10.1016/j.ijrobp.2010.12.072. Epub 2011 Apr 12.
7
Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report.依托泊苷和顺铂治疗小细胞肺癌转化患者获得意外良好结果:病例报告。
Cancer Biol Ther. 2019;20(9):1172-1175. doi: 10.1080/15384047.2019.1617561. Epub 2019 Jun 4.
8
Local radiotherapy in extensive-stage small-cell lung cancer sustainably boosts the clinical benefit of first-line immunotherapy: a case report.广泛期小细胞肺癌局部放疗可持续提高一线免疫治疗的临床获益:病例报告。
Front Immunol. 2024 Nov 1;15:1493740. doi: 10.3389/fimmu.2024.1493740. eCollection 2024.
9
Small Cell Lung Cancer.小细胞肺癌
Semin Respir Crit Care Med. 2016 Oct;37(5):783-796. doi: 10.1055/s-0036-1592116. Epub 2016 Oct 12.
10
Efficacy analysis and prognostic factors of first-line chemotherapy combined with immunotherapy in extensive-stage small cell lung cancer: a real-world study.广泛期小细胞肺癌一线化疗联合免疫治疗的疗效分析及预后因素:一项真实世界研究
Sci Rep. 2025 Apr 16;15(1):13063. doi: 10.1038/s41598-025-98018-8.

本文引用的文献

1
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis.中医药联合化疗治疗小细胞肺癌的疗效和安全性:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2020 Nov;146(11):2913-2935. doi: 10.1007/s00432-020-03353-0. Epub 2020 Aug 14.
2
Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.生江泻心汤预防小细胞肺癌患者化疗相关性腹泻的疗效和安全性:一项多中心随机对照试验的研究方案。
Trials. 2020 May 1;21(1):370. doi: 10.1186/s13063-020-04275-5.
3
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC).
肿瘤靶向药物偶联物作为小细胞肺癌(SCLC)中一种新兴的新型治疗方法。
Cancers (Basel). 2019 Sep 3;11(9):1297. doi: 10.3390/cancers11091297.
4
Immunotherapy for small-cell lung cancer: emerging evidence.小细胞肺癌的免疫疗法:新出现的证据。
Future Oncol. 2016 Apr;12(7):931-43. doi: 10.2217/fon-2015-0012. Epub 2016 Feb 17.
5
Chinese herbal decoction based on syndrome differentiation as maintenance therapy in patients with extensive-stage small-cell lung cancer: an exploratory and small prospective cohort study.基于辨证论治的中药复方在广泛期小细胞肺癌患者维持治疗中的应用:一项探索性、小样本前瞻性队列研究。
Evid Based Complement Alternat Med. 2015;2015:601067. doi: 10.1155/2015/601067. Epub 2015 Mar 1.
6
Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.小细胞肺癌的治疗:肺癌的诊断与管理,第 3 版:美国胸科学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e400S-e419S. doi: 10.1378/chest.12-2363.
7
Molecular analysis-based treatment strategies for non-small cell lung cancer.基于分子分析的非小细胞肺癌治疗策略
Cancer Control. 2008 Apr;15(2):130-9. doi: 10.1177/107327480801500205.
8
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.过去30年美国小细胞肺癌流行病学的变化:监测、流行病学和最终结果数据库分析
J Clin Oncol. 2006 Oct 1;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859.